Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 153 Lung Neoplasms 69 Carcinoma, Hepatocellular 63 Small Cell Lung Carcinoma 48 Breast Neoplasms 47 Squamous Cell Carcinoma of Head and Neck 35 Urinary Bladder Neoplasms 30 Colorectal Neoplasms 30 Biliary Tract Neoplasms 29 Neoplasms 28 Neoplasm Metastasis 28 Cholangiocarcinoma 27 Pancreatic Neoplasms 26 Triple Negative Breast Neoplasms 25 Ovarian Neoplasms 24 Liver Neoplasms 18 Head and Neck Neoplasms 18 Carcinoma, Renal Cell 17 Recurrence 16 Melanoma 14 Stomach Neoplasms 13 Prostatic Neoplasms 13 Carcinoma 13 Endometrial Neoplasms 12 Uterine Cervical Neoplasms 11 Esophageal Neoplasms 11 Carcinoma, Transitional Cell 11 Lymphoma, Large B-Cell, Diffuse 10 Gallbladder Neoplasms 9 Adenocarcinoma Of Esophagus 9

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Interleukin-2 9 Melphalan 8 CTLA-4 Antigen 8 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 tebentafusp 6 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Blood Specimen Collection 4 Biopsy 4 trametinib 3 sotrastaurin 3 relatlimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × durvalumab × Clear all

NCT04184518 2020-06-02

CEDUVEAL-M

Grupo Español Multidisciplinar de Melanoma

Phase 2 Withdrawn

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡